Guidance Recap Podcast | General Clinical Pharmacology Considerations for Neonatal Studies for Drugs and Biological Products
Guidance Recap Podcast: General Clinical Pharmacology Considerations for Neonatal Studies for Drugs and Biological Products
FDA to Compounders: Know Your Bulks and Excipients Suppliers
FDA has identified several issues over the past few years related to repackers of bulk drug substances, also called active…
GDUFA Implementation Quarterly Meetings between FDA and Industry
FDA and representatives of the generic drug industry meet quarterly to discuss topics related to the implementation of GDUFA.
Planning an EL-PFDD Meeting
Planning an EL-PFDD Meeting
Characterising a New Cannabis Trend: Extensive Analysis of Semi‐Synthetic Cannabinoid‐Containing Seizures From Germany
A LC–MS/MS method has been validated for analysis of semi-synthetic cannabinoids (SSC) and selected phytocannabinoids in seizures. Further SSC-derivatives were…
A method for detecting gene doping in horse sports without DNA extraction
We developed direct droplet digital PCR (ddPCR) and nested ddPCR to detect the equine erythropoietin (EPO) transgene without DNA extraction,…
Assessing EPO stability in urine and comparing recombinant EPO detectability in matched urine, venous serum, and capillary serum following a controlled epoetin alfa administration
A single dose of rEPO was administered to twelve healthy volunteers. EPO stability in urine was assessed at different storage…
Issue Information
No abstract is available for this article.
In memoriam
Drug Testing and Analysis, Volume 17, Issue 3, Page 397-398, March 2025.
Peter Haywood
Drug Testing and Analysis, Volume 17, Issue 3, Page 396-396, March 2025.